SlideShare ist ein Scribd-Unternehmen logo
1 von 32
Downloaden Sie, um offline zu lesen
Compliance with
Narcotics Guidelines
        April 10-12, 2012
 Walt Disney World Swan Resort
Accepted Learning Objectives:
1.  Describe how managed care programs, employers, health
    care providers and insurers are susceptible to increased
    workers compensation costs due to prescription drug abuse.

2.  Identify strategies employers and medical professionals can
    use to help drug-dependent and addicted employees regain
    control of their lives and return to work using results of
    CompPharma’s survey, “Prescription Drug Management in
    Workers’ Compensation – The Eighth Annual Survey.”

3.  Describe how Washington State has addressed the over use
    of opioids in workers’ compensation.
Disclosure Statement
•  Joseph Paduda has disclosed that he
   has a relationship with Reckitt
   Benckiser’s Suboxone Sublingual Film.
•  Dr. Richard A. Victor has disclosed no
   relevant, real or apparent personal or
   professional financial relationships.
Narcotics Use And
Compliance With
   Guidelines
 Richard Victor, J.D., Ph.D.
    Executive Director
  Workers Compensation
     Research Institute
Today s Outline
•  About heath care in workers
   compensation
•  Relevant findings from 2 WCRI studies
•  About WCRI
About Workers Compensation
•  Century-old social program
•  Injured workers receive medical care, income
   benefits, rehabilitation
•  Patients entitled by law to all necessary care
•  Patients have no deductibles or copayments,
   no formularies or step therapy
•  Physician dispensing is common in a growing
   number of states
•  Prices near AWP
Workers Compensation Facts
•  Employers pay $79 billion in 2008
•  Medical care represents more than
   half of the cost
•  4.6 million work-injuries
•  2.3 million involve lost time from work
•  20% of total—lost more than 1 week
   from work
•  Median lost time is 16 weeks
Common Medical Conditions In
  Workers Compensation
Medical Condition                              % Of Cases
Spine conditions
   Sprain, strain and nonspecific spine pain      21%
   Neurologic spine pain                          7%
Other musculoskeletal conditions
   Non-spine sprain and strain                    15%
   Shoulder inflammation                          7%
   Knee derangement                               4%
   Carpal tunnel syndrome                         2%
Trauma
   Fractures                                      10%
   Laceration or contusion                        12%
Other conditions                                  21%


            Cases With > 7 Days Of Lost Time
Today s Outline
•  About heath care in workers
   compensation
 Relevant findings from 2 WCRI studies
•  About WCRI
Two WCRI Studies Of Area
Variations In Prescribing Patterns
Major Findings From
WCRI Narcotics Studies
Data
•  Nonsurgical cases
•  Patients lost more than 1 week from work
•  Results presented for episodes of
   disability
•  Snapshot at an average of 24 months
   after injury
Data
•  17 states that represent more than 60%
   of WC benefits in the U.S.
•  360,000 Rx for 75,000 nonsurgical
   episodes of disability
•  16% to 50% of all episodes in each
   state
Most Patients Get Rx Pain Medication




   Nonsurgical Claims With > 7 Days Of Lost Time,
   Injuries From October 2005 To September 2006,
       Prescriptions Filled Through March 2008
Most Patients Get Narcotics




Nonsurgical Claims With > 7 Days Of Lost Time,
Injuries From October 2005 To September 2006,
    Prescriptions Filled Through March 2008
Unusually High Use Of Narcotics
   In NY, LA, PA, And MA




 Nonsurgical Claims With > 7 Days Of Lost Time,
 Injuries From October 2005 To September 2006,
     Prescriptions Filled Through March 2008
Also Higher Use Of Narcotics
  In CA, MD, NC, And TX




Nonsurgical Claims With > 7 Days Of Lost Time,
Injuries From October 2005 To September 2006,
    Prescriptions Filled Through March 2008
Average Worker In Four States Had More
 Narcotic Pills Per Episode Of Disability




   Nonsurgical Claims With > 7 Days Of Lost Time,
   Injuries From October 2005 To September 2006,
       Prescriptions Filled Through March 2008
Practice Patterns Favor Schedule II Narcotics
     In Northeast & Mid-Atlantic States




   Nonsurgical Claims With > 7 Days Of Lost Time,
   Injuries From October 2005 To September 2006,
       Prescriptions Filled Through March 2008
Major Findings From
WCRI Narcotics Studies
Longer-Term Use Of Narcotics
•  Study definition
  –  First narcotic Rx filled within first 3 months
     after injury
  –  Narcotics continued after 6 months
     post-injury
  –  3+ Rx fills during months 7–12
•  Nonsurgical cases
Longer-Term Use Common
 In Louisiana And New York




Nonsurgical Claims With > 7 Days Of Lost Time,
Injuries From October 2005 To September 2006,
    Prescriptions Filled Through March 2008
Longer-Term Use Also More Likely
   In PA, TX, CA, MA, And NC




 Nonsurgical Claims With > 7 Days Of Lost Time,
 Injuries From October 2005 To September 2006,
     Prescriptions Filled Through March 2008
VeryModest Interstate Variation In At
     Substantial Interstate Variation
    Substantial Interstate Variation
Median MEUs 90thEpisode of Disability
         The Per Percentile
                                                  50th Percentile      75th Percentile         90th Percentile
Morphine Equivalent Units Per Claim




                                  Nonsurgical Claims With > 7 Days Of Lost Time That Were
                                 Identified As Longer-Term Users Of Narcotics, Injuries From
                                    October 2005 To September 2006, Prescriptions Filled
                                                    Through March 2008
Common Guideline Recommendations
  For Monitoring & Management
Few Longer-Term Users Received
Services For Monitoring/Management




 Nonsurgical Claims With > 7 Days Of Lost Time That Were
Identified As Longer-Term Users Of Narcotics, Injuries From
   October 2005 To September 2006, Prescriptions Filled
                   Through March 2008
Few Longer-Term Users Received
Services For Monitoring/Management




 Nonsurgical Claims With > 7 Days Of Lost Time That Were
Identified As Longer-Term Users Of Narcotics, Injuries From
   October 2005 To September 2006, Prescriptions Filled
                   Through March 2008
Today s Outline
•  About heath care in workers
   compensation
•  Relevant findings from 2 WCRI studies
 About WCRI
About WCRI
•  Nation s largest independent think
   tank on workers compensation public
   policy issues
•  Published hundreds of peer-reviewed
   studies since founding in 1983
•  Membership organization—diverse
•  Not make recommendations nor take
   positions on issues
About WCRI: Focus Of Current
Health Policy Research Agenda
About WCRI: Focus Of Current
Health Policy Research Agenda
Today s Outline

Weitere ähnliche Inhalte

Was ist angesagt?

Medical Marijuana in Canada - Has Everything Changed?
Medical Marijuana in Canada - Has Everything Changed?Medical Marijuana in Canada - Has Everything Changed?
Medical Marijuana in Canada - Has Everything Changed?Canadian Cancer Survivor Network
 
Canada Market Access Briefing
Canada Market Access BriefingCanada Market Access Briefing
Canada Market Access BriefingMichael Jacobson
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroOPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerOPUNITE
 
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenRx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenOPUNITE
 
Pdmp 5 hopkins dreyzehner_o_leary
Pdmp 5 hopkins dreyzehner_o_learyPdmp 5 hopkins dreyzehner_o_leary
Pdmp 5 hopkins dreyzehner_o_learyOPUNITE
 
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)Canadian Organization for Rare Disorders
 
Ocular gene transfer:Developing an ethical framework to communicate clinical ...
Ocular gene transfer:Developing an ethical framework to communicate clinical ...Ocular gene transfer:Developing an ethical framework to communicate clinical ...
Ocular gene transfer:Developing an ethical framework to communicate clinical ...Canadian Organization for Rare Disorders
 
The Feds Are Coming! Session One: The Rules Have Changed
The Feds Are Coming! Session One: The Rules Have ChangedThe Feds Are Coming! Session One: The Rules Have Changed
The Feds Are Coming! Session One: The Rules Have ChangedPolsinelli PC
 
Rx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherRx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherOPUNITE
 
Prescriptive Authority
Prescriptive AuthorityPrescriptive Authority
Prescriptive Authoritybodo-con
 
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...Canadian Organization for Rare Disorders
 
Accessibility of medical marijuana
Accessibility of medical marijuanaAccessibility of medical marijuana
Accessibility of medical marijuanaJonathanJuca
 

Was ist angesagt? (20)

Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
Story to Sepsis Screen: A Journey in the Details by Elizabeth R. Alpern, MD, ...
 
Medical Marijuana in Canada - Has Everything Changed?
Medical Marijuana in Canada - Has Everything Changed?Medical Marijuana in Canada - Has Everything Changed?
Medical Marijuana in Canada - Has Everything Changed?
 
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
 
Rare Disease access issues 2015 v2
Rare Disease access issues 2015 v2Rare Disease access issues 2015 v2
Rare Disease access issues 2015 v2
 
Canada Market Access Briefing
Canada Market Access BriefingCanada Market Access Briefing
Canada Market Access Briefing
 
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiroWeb only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
Web only rx16 pdmp-tues_330_1_kreiner_2ringwalt-schiro
 
Drug Access Navigation - An Insider's Perspective
Drug Access Navigation - An Insider's PerspectiveDrug Access Navigation - An Insider's Perspective
Drug Access Navigation - An Insider's Perspective
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 
A Brief History of the CDFI
A Brief History of the CDFIA Brief History of the CDFI
A Brief History of the CDFI
 
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4travenRx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
Rx16 pdmp tues_1230_1_small_2kreiner_3baumgartner_4traven
 
Pdmp 5 hopkins dreyzehner_o_leary
Pdmp 5 hopkins dreyzehner_o_learyPdmp 5 hopkins dreyzehner_o_leary
Pdmp 5 hopkins dreyzehner_o_leary
 
Funding of Drugs for Rare Diseases Provincial Program Perspective
Funding of Drugs for Rare Diseases Provincial Program PerspectiveFunding of Drugs for Rare Diseases Provincial Program Perspective
Funding of Drugs for Rare Diseases Provincial Program Perspective
 
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)
Evidence-Based Approach to Assuring Value for Orphan Drugs: Pam Gavin (NORD)
 
Ocular gene transfer:Developing an ethical framework to communicate clinical ...
Ocular gene transfer:Developing an ethical framework to communicate clinical ...Ocular gene transfer:Developing an ethical framework to communicate clinical ...
Ocular gene transfer:Developing an ethical framework to communicate clinical ...
 
The Feds Are Coming! Session One: The Rules Have Changed
The Feds Are Coming! Session One: The Rules Have ChangedThe Feds Are Coming! Session One: The Rules Have Changed
The Feds Are Coming! Session One: The Rules Have Changed
 
Rx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisherRx16 tpp tues_200_1_bartlett-peak_2fisher
Rx16 tpp tues_200_1_bartlett-peak_2fisher
 
Prescriptive Authority
Prescriptive AuthorityPrescriptive Authority
Prescriptive Authority
 
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Diseas...
 
Accessibility of medical marijuana
Accessibility of medical marijuanaAccessibility of medical marijuana
Accessibility of medical marijuana
 
How Prescription Drugs are Approved in Canada
How Prescription Drugs are Approved in CanadaHow Prescription Drugs are Approved in Canada
How Prescription Drugs are Approved in Canada
 

Andere mochten auch

Rollin Gallagher
Rollin GallagherRollin Gallagher
Rollin GallagherOPUNITE
 
Mike Townsend
Mike TownsendMike Townsend
Mike TownsendOPUNITE
 
Carol Boyd
Carol BoydCarol Boyd
Carol BoydOPUNITE
 
Robert Sproul
Robert SproulRobert Sproul
Robert SproulOPUNITE
 
Ismposter
Ismposter Ismposter
Ismposter Ardi Green
 
Gary Martin2
Gary Martin2Gary Martin2
Gary Martin2OPUNITE
 
Joseph Paduda
Joseph PadudaJoseph Paduda
Joseph PadudaOPUNITE
 
Sarah Melton
Sarah MeltonSarah Melton
Sarah MeltonOPUNITE
 
Michael-Ward
Michael-WardMichael-Ward
Michael-WardOPUNITE
 
Leslie Balonick
Leslie BalonickLeslie Balonick
Leslie BalonickOPUNITE
 
Michelle Lipinski
Michelle LipinskiMichelle Lipinski
Michelle LipinskiOPUNITE
 
CLAAD/ Safe BTW
CLAAD/ Safe BTWCLAAD/ Safe BTW
CLAAD/ Safe BTWOPUNITE
 
Gary Franklin
Gary FranklinGary Franklin
Gary FranklinOPUNITE
 
Benson-Marshall-Matthew
Benson-Marshall-MatthewBenson-Marshall-Matthew
Benson-Marshall-MatthewOPUNITE
 
Alex Cahana
Alex CahanaAlex Cahana
Alex CahanaOPUNITE
 
Dr. Ileana Arias
Dr. Ileana AriasDr. Ileana Arias
Dr. Ileana AriasOPUNITE
 
Karen Perry
Karen PerryKaren Perry
Karen PerryOPUNITE
 
Kelly Clark
Kelly ClarkKelly Clark
Kelly ClarkOPUNITE
 
Heuser-Desmond
Heuser-DesmondHeuser-Desmond
Heuser-DesmondOPUNITE
 
Andrew Kolodny
Andrew KolodnyAndrew Kolodny
Andrew KolodnyOPUNITE
 

Andere mochten auch (20)

Rollin Gallagher
Rollin GallagherRollin Gallagher
Rollin Gallagher
 
Mike Townsend
Mike TownsendMike Townsend
Mike Townsend
 
Carol Boyd
Carol BoydCarol Boyd
Carol Boyd
 
Robert Sproul
Robert SproulRobert Sproul
Robert Sproul
 
Ismposter
Ismposter Ismposter
Ismposter
 
Gary Martin2
Gary Martin2Gary Martin2
Gary Martin2
 
Joseph Paduda
Joseph PadudaJoseph Paduda
Joseph Paduda
 
Sarah Melton
Sarah MeltonSarah Melton
Sarah Melton
 
Michael-Ward
Michael-WardMichael-Ward
Michael-Ward
 
Leslie Balonick
Leslie BalonickLeslie Balonick
Leslie Balonick
 
Michelle Lipinski
Michelle LipinskiMichelle Lipinski
Michelle Lipinski
 
CLAAD/ Safe BTW
CLAAD/ Safe BTWCLAAD/ Safe BTW
CLAAD/ Safe BTW
 
Gary Franklin
Gary FranklinGary Franklin
Gary Franklin
 
Benson-Marshall-Matthew
Benson-Marshall-MatthewBenson-Marshall-Matthew
Benson-Marshall-Matthew
 
Alex Cahana
Alex CahanaAlex Cahana
Alex Cahana
 
Dr. Ileana Arias
Dr. Ileana AriasDr. Ileana Arias
Dr. Ileana Arias
 
Karen Perry
Karen PerryKaren Perry
Karen Perry
 
Kelly Clark
Kelly ClarkKelly Clark
Kelly Clark
 
Heuser-Desmond
Heuser-DesmondHeuser-Desmond
Heuser-Desmond
 
Andrew Kolodny
Andrew KolodnyAndrew Kolodny
Andrew Kolodny
 

Ähnlich wie Richard Victor

Rx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageRx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageOPUNITE
 
Administrative Burden: Legislative and Regulatory Advocacy to Improve Physici...
Administrative Burden: Legislative and Regulatory Advocacy to Improve Physici...Administrative Burden: Legislative and Regulatory Advocacy to Improve Physici...
Administrative Burden: Legislative and Regulatory Advocacy to Improve Physici...American Academy of Family Physicians
 
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyRx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyOPUNITE
 
원격 의료 산업의 글로벌 동향 및 주요 이슈
원격 의료 산업의 글로벌 동향 및 주요 이슈원격 의료 산업의 글로벌 동향 및 주요 이슈
원격 의료 산업의 글로벌 동향 및 주요 이슈Yoon Sup Choi
 
Rx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsRx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsOPUNITE
 
Shannon_Zhang_Project_Presentation_Disclaimer_Credits
Shannon_Zhang_Project_Presentation_Disclaimer_CreditsShannon_Zhang_Project_Presentation_Disclaimer_Credits
Shannon_Zhang_Project_Presentation_Disclaimer_CreditsShannon-Xiaohan Zhang MS
 
Rx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerRx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerOPUNITE
 
Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?RIAPA
 
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019Canadian Organization for Rare Disorders
 
Cost saving strategies_updated
Cost saving strategies_updatedCost saving strategies_updated
Cost saving strategies_updatedOPUNITE
 
FLAACOs 2014 Conference - CVS Health: Collaborating with Providers
FLAACOs 2014 Conference - CVS Health: Collaborating with ProvidersFLAACOs 2014 Conference - CVS Health: Collaborating with Providers
FLAACOs 2014 Conference - CVS Health: Collaborating with ProvidersMARCYINC
 
New mexicoap npp
New mexicoap nppNew mexicoap npp
New mexicoap nppDoraWong10
 
Rx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaRx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaOPUNITE
 
Rx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notesRx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notesOPUNITE
 
Midlevel Operations: Exploring New Expsoures with Allied Health Providers
Midlevel Operations: Exploring New Expsoures with Allied Health ProvidersMidlevel Operations: Exploring New Expsoures with Allied Health Providers
Midlevel Operations: Exploring New Expsoures with Allied Health ProvidersSedgwick
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...University of Michigan Injury Center
 

Ähnlich wie Richard Victor (20)

State Strategies for Administrative Simplification
State Strategies for Administrative SimplificationState Strategies for Administrative Simplification
State Strategies for Administrative Simplification
 
Rx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptageRx15 tpp tues_1230_allen-emptage
Rx15 tpp tues_1230_allen-emptage
 
Administrative Burden: Legislative and Regulatory Advocacy to Improve Physici...
Administrative Burden: Legislative and Regulatory Advocacy to Improve Physici...Administrative Burden: Legislative and Regulatory Advocacy to Improve Physici...
Administrative Burden: Legislative and Regulatory Advocacy to Improve Physici...
 
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramseyRx15 pdmp wed_430_1_stanton_2blake_3ramsey
Rx15 pdmp wed_430_1_stanton_2blake_3ramsey
 
원격 의료 산업의 글로벌 동향 및 주요 이슈
원격 의료 산업의 글로벌 동향 및 주요 이슈원격 의료 산업의 글로벌 동향 및 주요 이슈
원격 의료 산업의 글로벌 동향 및 주요 이슈
 
Rx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williamsRx16 tpp tues_1230_1_worthy_2williams
Rx16 tpp tues_1230_1_worthy_2williams
 
Shannon_Zhang_Project_Presentation_Disclaimer_Credits
Shannon_Zhang_Project_Presentation_Disclaimer_CreditsShannon_Zhang_Project_Presentation_Disclaimer_Credits
Shannon_Zhang_Project_Presentation_Disclaimer_Credits
 
Rx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinnerRx15 tpp wed_1115_2_fisher_3skinner
Rx15 tpp wed_1115_2_fisher_3skinner
 
Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?Controlled Substance Prescribing: What to Do?
Controlled Substance Prescribing: What to Do?
 
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019
Day 1: 2:45pm- 4:00pm Panel Slides (Nov 18) Access to Innovation Conference 2019
 
Twillman preventing rx abuse
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
 
Cost saving strategies_updated
Cost saving strategies_updatedCost saving strategies_updated
Cost saving strategies_updated
 
FLAACOs 2014 Conference - CVS Health: Collaborating with Providers
FLAACOs 2014 Conference - CVS Health: Collaborating with ProvidersFLAACOs 2014 Conference - CVS Health: Collaborating with Providers
FLAACOs 2014 Conference - CVS Health: Collaborating with Providers
 
New mexicoap npp
New mexicoap nppNew mexicoap npp
New mexicoap npp
 
Telehealth Regulatory Potential Across State Lines
Telehealth Regulatory Potential Across State LinesTelehealth Regulatory Potential Across State Lines
Telehealth Regulatory Potential Across State Lines
 
Rx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hannaRx15 tpp wed_300_1_paduda-white_2hanna
Rx15 tpp wed_300_1_paduda-white_2hanna
 
Rx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notesRx15 workshop mon_200_aleshire_dowell_no_notes
Rx15 workshop mon_200_aleshire_dowell_no_notes
 
Midlevel Operations: Exploring New Expsoures with Allied Health Providers
Midlevel Operations: Exploring New Expsoures with Allied Health ProvidersMidlevel Operations: Exploring New Expsoures with Allied Health Providers
Midlevel Operations: Exploring New Expsoures with Allied Health Providers
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
 

Mehr von OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 

Mehr von OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 

KĂźrzlich hochgeladen

Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.Vinodha Devi
 
The Economic History of the U.S. Lecture 23.pdf
The Economic History of the U.S. Lecture 23.pdfThe Economic History of the U.S. Lecture 23.pdf
The Economic History of the U.S. Lecture 23.pdfGale Pooley
 
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...Call Girls in Nagpur High Profile
 
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur EscortsHigh Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...dipikadinghjn ( Why You Choose Us? ) Escorts
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignHenry Tapper
 
The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfGale Pooley
 
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdfFinTech Belgium
 
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...dipikadinghjn ( Why You Choose Us? ) Escorts
 
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptxFinTech Belgium
 
00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptxFinTech Belgium
 
20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdfAdnet Communications
 
Indore Real Estate Market Trends Report.pdf
Indore Real Estate Market Trends Report.pdfIndore Real Estate Market Trends Report.pdf
Indore Real Estate Market Trends Report.pdfSaviRakhecha1
 
Pooja 9892124323 : Call Girl in Juhu Escorts Service Free Home Delivery
Pooja 9892124323 : Call Girl in Juhu Escorts Service Free Home DeliveryPooja 9892124323 : Call Girl in Juhu Escorts Service Free Home Delivery
Pooja 9892124323 : Call Girl in Juhu Escorts Service Free Home DeliveryPooja Nehwal
 
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual serviceCALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual serviceanilsa9823
 
The Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfThe Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfGale Pooley
 
The Economic History of the U.S. Lecture 26.pdf
The Economic History of the U.S. Lecture 26.pdfThe Economic History of the U.S. Lecture 26.pdf
The Economic History of the U.S. Lecture 26.pdfGale Pooley
 
The Economic History of the U.S. Lecture 20.pdf
The Economic History of the U.S. Lecture 20.pdfThe Economic History of the U.S. Lecture 20.pdf
The Economic History of the U.S. Lecture 20.pdfGale Pooley
 
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...Call Girls in Nagpur High Profile
 
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...ranjana rawat
 

KĂźrzlich hochgeladen (20)

Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.Gurley shaw Theory of Monetary Economics.
Gurley shaw Theory of Monetary Economics.
 
The Economic History of the U.S. Lecture 23.pdf
The Economic History of the U.S. Lecture 23.pdfThe Economic History of the U.S. Lecture 23.pdf
The Economic History of the U.S. Lecture 23.pdf
 
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
VVIP Pune Call Girls Katraj (7001035870) Pune Escorts Nearby with Complete Sa...
 
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur EscortsHigh Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
 
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
VIP Independent Call Girls in Andheri 🌹 9920725232 ( Call Me ) Mumbai Escorts...
 
Log your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaignLog your LOA pain with Pension Lab's brilliant campaign
Log your LOA pain with Pension Lab's brilliant campaign
 
The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdf
 
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
 
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
VIP Call Girl in Mira Road 💧 9920725232 ( Call Me ) Get A New Crush Everyday ...
 
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
 
00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx
 
20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf20240429 Calibre April 2024 Investor Presentation.pdf
20240429 Calibre April 2024 Investor Presentation.pdf
 
Indore Real Estate Market Trends Report.pdf
Indore Real Estate Market Trends Report.pdfIndore Real Estate Market Trends Report.pdf
Indore Real Estate Market Trends Report.pdf
 
Pooja 9892124323 : Call Girl in Juhu Escorts Service Free Home Delivery
Pooja 9892124323 : Call Girl in Juhu Escorts Service Free Home DeliveryPooja 9892124323 : Call Girl in Juhu Escorts Service Free Home Delivery
Pooja 9892124323 : Call Girl in Juhu Escorts Service Free Home Delivery
 
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual serviceCALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
CALL ON ➥8923113531 🔝Call Girls Gomti Nagar Lucknow best sexual service
 
The Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfThe Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdf
 
The Economic History of the U.S. Lecture 26.pdf
The Economic History of the U.S. Lecture 26.pdfThe Economic History of the U.S. Lecture 26.pdf
The Economic History of the U.S. Lecture 26.pdf
 
The Economic History of the U.S. Lecture 20.pdf
The Economic History of the U.S. Lecture 20.pdfThe Economic History of the U.S. Lecture 20.pdf
The Economic History of the U.S. Lecture 20.pdf
 
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...Booking open Available Pune Call Girls Shivane  6297143586 Call Hot Indian Gi...
Booking open Available Pune Call Girls Shivane 6297143586 Call Hot Indian Gi...
 
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
(DIYA) Bhumkar Chowk Call Girls Just Call 7001035870 [ Cash on Delivery ] Pun...
 

Richard Victor

  • 1. Compliance with Narcotics Guidelines April 10-12, 2012 Walt Disney World Swan Resort
  • 2. Accepted Learning Objectives: 1.  Describe how managed care programs, employers, health care providers and insurers are susceptible to increased workers compensation costs due to prescription drug abuse. 2.  Identify strategies employers and medical professionals can use to help drug-dependent and addicted employees regain control of their lives and return to work using results of CompPharma’s survey, “Prescription Drug Management in Workers’ Compensation – The Eighth Annual Survey.” 3.  Describe how Washington State has addressed the over use of opioids in workers’ compensation.
  • 3. Disclosure Statement •  Joseph Paduda has disclosed that he has a relationship with Reckitt Benckiser’s Suboxone Sublingual Film. •  Dr. Richard A. Victor has disclosed no relevant, real or apparent personal or professional financial relationships.
  • 4. Narcotics Use And Compliance With Guidelines Richard Victor, J.D., Ph.D. Executive Director Workers Compensation Research Institute
  • 5. Today s Outline •  About heath care in workers compensation •  Relevant findings from 2 WCRI studies •  About WCRI
  • 6. About Workers Compensation •  Century-old social program •  Injured workers receive medical care, income benefits, rehabilitation •  Patients entitled by law to all necessary care •  Patients have no deductibles or copayments, no formularies or step therapy •  Physician dispensing is common in a growing number of states •  Prices near AWP
  • 7. Workers Compensation Facts •  Employers pay $79 billion in 2008 •  Medical care represents more than half of the cost •  4.6 million work-injuries •  2.3 million involve lost time from work •  20% of total—lost more than 1 week from work •  Median lost time is 16 weeks
  • 8. Common Medical Conditions In Workers Compensation Medical Condition % Of Cases Spine conditions Sprain, strain and nonspecific spine pain 21% Neurologic spine pain 7% Other musculoskeletal conditions Non-spine sprain and strain 15% Shoulder inflammation 7% Knee derangement 4% Carpal tunnel syndrome 2% Trauma Fractures 10% Laceration or contusion 12% Other conditions 21% Cases With > 7 Days Of Lost Time
  • 9. Today s Outline •  About heath care in workers compensation  Relevant findings from 2 WCRI studies •  About WCRI
  • 10. Two WCRI Studies Of Area Variations In Prescribing Patterns
  • 11. Major Findings From WCRI Narcotics Studies
  • 12. Data •  Nonsurgical cases •  Patients lost more than 1 week from work •  Results presented for episodes of disability •  Snapshot at an average of 24 months after injury
  • 13. Data •  17 states that represent more than 60% of WC benefits in the U.S. •  360,000 Rx for 75,000 nonsurgical episodes of disability •  16% to 50% of all episodes in each state
  • 14. Most Patients Get Rx Pain Medication Nonsurgical Claims With > 7 Days Of Lost Time, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 15. Most Patients Get Narcotics Nonsurgical Claims With > 7 Days Of Lost Time, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 16. Unusually High Use Of Narcotics In NY, LA, PA, And MA Nonsurgical Claims With > 7 Days Of Lost Time, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 17. Also Higher Use Of Narcotics In CA, MD, NC, And TX Nonsurgical Claims With > 7 Days Of Lost Time, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 18. Average Worker In Four States Had More Narcotic Pills Per Episode Of Disability Nonsurgical Claims With > 7 Days Of Lost Time, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 19. Practice Patterns Favor Schedule II Narcotics In Northeast & Mid-Atlantic States Nonsurgical Claims With > 7 Days Of Lost Time, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 20. Major Findings From WCRI Narcotics Studies
  • 21. Longer-Term Use Of Narcotics •  Study definition –  First narcotic Rx filled within first 3 months after injury –  Narcotics continued after 6 months post-injury –  3+ Rx fills during months 7–12 •  Nonsurgical cases
  • 22. Longer-Term Use Common In Louisiana And New York Nonsurgical Claims With > 7 Days Of Lost Time, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 23. Longer-Term Use Also More Likely In PA, TX, CA, MA, And NC Nonsurgical Claims With > 7 Days Of Lost Time, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 24. VeryModest Interstate Variation In At Substantial Interstate Variation Substantial Interstate Variation Median MEUs 90thEpisode of Disability The Per Percentile 50th Percentile 75th Percentile 90th Percentile Morphine Equivalent Units Per Claim Nonsurgical Claims With > 7 Days Of Lost Time That Were Identified As Longer-Term Users Of Narcotics, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 25. Common Guideline Recommendations For Monitoring & Management
  • 26. Few Longer-Term Users Received Services For Monitoring/Management Nonsurgical Claims With > 7 Days Of Lost Time That Were Identified As Longer-Term Users Of Narcotics, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 27. Few Longer-Term Users Received Services For Monitoring/Management Nonsurgical Claims With > 7 Days Of Lost Time That Were Identified As Longer-Term Users Of Narcotics, Injuries From October 2005 To September 2006, Prescriptions Filled Through March 2008
  • 28. Today s Outline •  About heath care in workers compensation •  Relevant findings from 2 WCRI studies  About WCRI
  • 29. About WCRI •  Nation s largest independent think tank on workers compensation public policy issues •  Published hundreds of peer-reviewed studies since founding in 1983 •  Membership organization—diverse •  Not make recommendations nor take positions on issues
  • 30. About WCRI: Focus Of Current Health Policy Research Agenda
  • 31. About WCRI: Focus Of Current Health Policy Research Agenda